Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Operating Leases (2017 - 2025)

AC Immune (ACIU) has disclosed Operating Leases for 7 consecutive years, with $5.0 million as the latest value for Q4 2024.

  • On a quarterly basis, Operating Leases rose 57.75% to $5.0 million in Q4 2024 year-over-year; TTM through Dec 2024 was $5.0 million, a 57.75% increase, with the full-year FY2024 number at $5.0 million, up 59.72% from a year prior.
  • Operating Leases was $5.0 million for Q4 2024 at AC Immune, up from $3.2 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $5.0 million in Q4 2024 to a low of $2.0 million in Q4 2020.
  • A 5-year average of $3.0 million and a median of $2.5 million in 2021 define the central range for Operating Leases.
  • Peak YoY movement for Operating Leases: fell 7.84% in 2022, then surged 57.75% in 2024.
  • AC Immune's Operating Leases stood at $2.0 million in 2020, then grew by 28.89% to $2.5 million in 2021, then dropped by 7.84% to $2.3 million in 2022, then skyrocketed by 36.18% to $3.2 million in 2023, then skyrocketed by 57.75% to $5.0 million in 2024.
  • Per Business Quant, the three most recent readings for ACIU's Operating Leases are $5.0 million (Q4 2024), $3.2 million (Q4 2023), and $2.3 million (Q4 2022).